CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

SI Bone

SI-BONE, Inc. (San Jose, California) is the leading sacroiliac joint medical device company dedicated to the development of tools and products for patients with low back issues related to certain SI joint disorders. The company has developed, and is manufacturing and marketing, minimally invasive products for patients with certain SI joint disorders. SI-BONE has an experienced management team with extensive experience in orthopedic and spine medical devices.

Talyst

Talyst enables positive change in the medication management process.

IMAC Regeneration Centers

IMAC Regeneration Centers offers long-term solutions for chronic musculoskeletal conditions without surgery or opioids. This state-of-the-art medical treatment utilizes a combination of regenerative medicine and rehabilitation to prevent the most common unnecessary surgeries, including spinal fusion and laminectomy, and knee and hip replacements. Each of these surgeries require an opioid prescription 99.9% of the time, leading to a high risk of addiction and never returning to work.

PharmCentre

PharmCentre is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

World Product Centre

World Product Centre is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.